|
Author(Year)
|
Sample size(n)
|
Age of participants
|
Dosage
|
Location
|
Quality score
|
Risk Ratio
|
%Weight using FEM*
|
|---|
|
Madhi et al. (2011) [19]
|
547
|
<4 months
|
10–20 mg/kg
|
South Africa and Botswana
|
5A
|
0.98(0.7,1.39)
|
32.4%
|
|
Madhi et al. (2011) [19]
|
806
|
<4 months
|
10–20 mg/kg
|
South Africa and Botswana
|
5A
|
0.86(0.57,1.29)
|
22.8%
|
|
Zar et al. (2007) [18]
|
263
|
<51 months
|
10(8–12)mg/kg
|
South Africa
|
5A
|
0.28(0.1,0.78)
|
3.6%
|
|
Gupta et al. (1993) [24]
|
167
|
5–15 years
|
15 mg/kg
|
India
|
1D
|
0.61(0.3,1.25)
|
7.5%
|
|
Debre et al. (1973) [22]
|
2,307
|
5–14 years
|
5–15 mg/kg
|
France
|
1D
|
0.40(0.15,1.05)
|
4.0%
|
|
Egsmose et al. (1965) [20]
|
406
|
0–15 years
|
5–10 mg/kg
|
Kenya
|
5A
|
0.38(0.16,0.88)
|
5.2%
|
|
Comstock et al. (1962) [23]
|
3,074
|
2 months–15 years
|
4–8 mg/kg
|
Alaska
|
5A
|
0.33(0.07,1.64)
|
1.5%
|
|
Mount et al. (1961) [25]
|
2,750
|
0–15 years
|
4–6 mg/kg
|
USA, Canada, Mexico
|
5A
|
0.40(0.27,0.61)
|
22.9%
|
|
Total
|
10,320
| | | | | |
100%
|
- *FEM-Fixed Effects Model.
